Infinite Biomedical Technologies
About Infinite Biomedical Technologies
Infinite Biomedical Technologies (IBT), established in 1997 as a spin-off from the Johns Hopkins School of Medicine, is a medical device company dedicated to advancing prosthetic technology for individuals with limb loss. Their core mission involves translating cutting-edge laboratory research into practical, real-world medical solutions that enhance the quality of life for amputees.
IBT specializes in developing innovative upper-limb prosthetic devices and sophisticated control systems. Key offerings include the Sense pattern recognition control system and Glide technology for intuitive myoelectric control, which interface with various commercially available prosthetic hands, wrists, and elbows. They also provide the MyoTrain virtual-limb pre-prosthetic training system, designed to facilitate skill transference for new users of pattern recognition prostheses, and FlexCell, a flexible lithium-polymer battery system for myoelectric prosthetics. The company’s focus extends to embedded control technologies and patient-driven augmented reality-based rehabilitation systems, aiming to provide reliable and comfortable solutions.
Focus Areas
Business Intelligence
| Key Investors | DARPA, NSF, NIH, National Institute of Child Health and Human Development, National Institute of Neurological Disorders and Stroke, Defense Health Agency |
| Partnerships | Johns Hopkins University, George Mason University, Dankmeyer, Inc., University of Colorado Boulder |
| Technology | Pattern recognition control systems (Sense, Glide), RFID tagging, Bluetooth interfacing, virtual-limb pre-prosthetic training system (MyoTrain), embedded control systems, flexible electronics, hardware, advanced machine learning algorithm design, app-based clinician and patient user interfaces (IBT Control App on iPad OS), sonomyographic prosthetic control |
| FDA Clearances | 7 cleared products (estimated) |
What Physicians Need to Know
For physicians, Infinite Biomedical Technologies stands out due to its commitment to enhancing patient quality of life through highly intuitive and compatible prosthetic solutions. Their 'Sense' and 'Glide' systems offer unparalleled precision and a personalized approach to myoelectric control, making advanced functionality accessible to a broader patient population, including those for whom standard myoelectric control was previously unsuitable. The broad compatibility of their control systems with most existing prosthetic hands, wrists, and elbows simplifies integration and offers flexibility in component selection. Furthermore, the 'MyoTrain' pre-prosthetic training system is a significant advantage, enabling patients to develop control skills before definitive prosthetic fitting, potentially leading to better adaptation and outcomes. IBT's strong foundation in Johns Hopkins research, evidenced by numerous peer-reviewed publications, patents, and grants, underscores their evidence-based approach to innovation. Their FDA-cleared devices also ensure regulatory compliance and safety for clinical use. Additionally, the design of IBT Electrodes with materials aimed at reducing skin irritation addresses a common patient concern.
Infinite Biomedical Technologies' control systems, such as 'Glide' and 'Sense', are designed for broad compatibility, interfacing with most myoelectric hands, wrists, and elbows available on the market. The 'Element' system is also compatible with most hands, wrists, and elbows that accept standard analog EMG electrode inputs. Their flexible battery system, 'FlexCell', is compatible with most upper limb prosthetic terminal devices. This extensive compatibility allows for seamless integration into existing prosthetic setups and offers flexibility for prosthetists in selecting components to meet individual patient needs.
Reviews & Opinions
Videos
News, demos, and interviews about Infinite Biomedical Technologies.
Videos load interactively. If none appear, search YouTube for Infinite Biomedical Technologies →
Press & Coverage
Frequently Asked Questions
Related Companies
QuickIntell is an AI-first healthcare technology company dedicated to transforming healthcare operations for physicians and healthcare providers. The company leverages advanced AI agents, including Computer Vision, Machine Learning, Optical Character Recognition (OCR), and Natural Language Processing (NLP), to streamline administrative workflows and enhance Revenue Cycle Management (RCM). QuickIntell’s solutions are designed to reduce administrative burden, […]
Ease Tax Relief, founded in 2016, is a tax relief and resolution company based in Harleysville, PA. The company specializes in helping individuals and small businesses resolve issues with the IRS, offering services such as Offer in Compromise, Partial Pay Installment Agreements, Payment Plans, and Penalty Reduction. Owned and operated by Zheng Yang, a CPA […]
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]